Skip to main content

Table 1 Patient characteristics

From: Long-term outcome after mitral valve replacement using biological versus mechanical valves

 

Total

N = 324

Biological MVR

N = 265

Mechanical MVR

N = 59

p-value

Age in years

69.0 [58.0–76.0] [324]

71.0 [62.0–77.0] [265]

56.0 [50.0–62.0] [59]

< 0.001

  ≤ 65 years, %

133/324 (41.0)

86/265 (32.5)

47/59 (79.7)

< 0.001

Female gender, %

161/324 (49.7)

137/265 (51.7)

24/59 (40.7)

0.126

BMI (kg/m2)

26.2 [23.2–29.0] [256]

26.2 [23.0–28.9] [214]

26.9 [23.2–31.7] [42]

0.337

CV risk factors

 Hypertension, %

173/324 (53.4)

147/265 (55.5)

26/59 (44.1)

0.112

 Dyslipidemia, %

52/324 (16.0)

46/265 (17.4)

6/59 (10.2)

0.174

Comorbidity general

 Diabetes mellitus, %

35/324 (10.8)

31/265 (11.7)

4/59 (6.8)

0.271

 Kidney failure (Crea. > 2.26 mg/dL)

8/324 (2.5)

7/265 (2.6)

1/59 (1.7)

1.000

 Stroke, %

30/324 (9.3)

27/265 (10.2)

3/59 (5.1)

0.221

 COPD, %

44/324 (13.6)

39/265 (14.7)

5/59 (8.5)

0.206

 PAD, %

17/324 (5.2)

16/265 (6.0)

1/59 (1.7)

0.328

Comorbidity cardiac

 Atrial fibrillation, %

126/324 (38.9)

102/265 (38.5)

24/59 (40.7)

0.755

 Coronary artery disease, %

45/324 (13.9)

41/265 (15.5)

4/59 (6.8)

0.081

 Prior MI (≤90 days), %

4/324 (1.2)

3/265 (1.1)

1/59 (1.7)

0.554

 Prior aortic valve replacement, %

15/324 (4.6)

11/265 (4.2)

4/59 (6.8)

0.489

 Prior CABG, %

25/324 (7.7)

23/265 (8.7)

2/59 (3.4)

0.277

 Prior pacemaker, %

13/324 (4.0)

11/265 (4.2)

2/59 (3.4)

1.000

 NYHA class III/IV, %

273/324 (84.3)

225/265 (84.9)

48/59 (81.4)

0.498

 CCS class III %a

16/324 (4.9)

12/265 (4.5)

4/59 (6.8)

0.505

 Pulmonary hypertension, %

56/324 (17.3)

47/265 (17.7)

9/59 (15.3)

0.648

Emergency indication for surgery, %

31/324 (9.6)

23/265 (8.7)

8/59 (13.6)

0.249

Cardiac decompensation, %

112/324 (34.6)

95/265 (35.8)

17/59 (28.8)

0.304

Log EuroSCORE I (%)

7.2 [3.5–15.6] [322]

8.4 [3.6–17.5] [263]

4.5 [2.9–8.0] [59]

< 0.001

  1. Legend: Values are patients applicable/patients with available information with percentage in brackets OR medians with IQR in brackets and available patient number in brackets; aNo patient presented with CCS class IV in this collective
  2. BMI body mass index, CV cardiovascular, CABG coronary artery bypass graft, CCS Canadian Cardiovascular Society, COPD chronic obstructive pulmonary disease, MI myocardial infarction, NYHA,New York Heart Association, PAD peripheral artery disease, SD standard deviation